A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus

A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus

SARS-CoV-2 infectivity is largely determined by the virus Spike protein binding to the ACE2 receptor. Meanwhile, marked infection rate differences were reported between populations and individuals. To understand the disease dynamic, we developed a computational approach to study the implications of...

Full description

Bibliographic Details
Main Authors:	Dana Ashoor, Noureddine Ben Khalaf, Maryam Marzouq, Hamdi Jarjanazi, Sadok Chlif, M. Dahmani Fathallah
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	COVID-19 SARS-CoV-2 angiotensin converting enzyme 2 receptor spike receptor binding domain virus-host interaction
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2021.707194/full

Similar Items

Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
by: Emily E. F. Brown, et al.
Published: (2021-02-01)

Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
by: Arun Bahadur Gurung, et al.
Published: (2021-02-01)

Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
by: Jiacheng Xiong, et al.
Published: (2021-09-01)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
by: Federica Saponaro, et al.
Published: (2020-09-01)

Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor
by: Young Soo Kim, et al.
Published: (2021-08-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
by: Bingqian Li, et al.
Published: (2021-07-01)

Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
by: Jingwei Bian, et al.
Published: (2021-01-01)

Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
by: Sk. Sarif Hassan, et al.
Published: (2020-12-01)

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells
by: Brini, M., et al.
Published: (2022)

Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
by: Yixin Xie, et al.
Published: (2020-12-01)

Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2
by: Kien Nguyen, et al.
Published: (2021-05-01)

Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages
by: Umesh Kalathiya, et al.
Published: (2021-02-01)

In silico study of intrinsic dynamics of full-length apo-ACE2 and RBD-ACE2 complex
by: Qing Liu, et al.
Published: (2021-01-01)

Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2
by: Pujarini Dash, et al.
Published: (2021-03-01)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
by: Sai Priya Anand, et al.
Published: (2020-09-01)

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
by: Michael I Barton, et al.
Published: (2021-08-01)

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
by: Federico Bertoglio, et al.
Published: (2021-07-01)

Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system
by: Michal Herman-Edelstein, et al.
Published: (2021-04-01)

Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2
by: Chuan-Jun Shu, et al.
Published: (2021-03-01)

Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19
by: Leandro Núñez-Muñoz, et al.
Published: (2021-08-01)

ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes
by: Lorenzo A. Calò, et al.
Published: (2021-05-01)

Attenuation of Myocardial Fibrosis with Curcumin Is Mediated by Modulating Expression of Angiotensin II AT1/AT2 Receptors and ACE2 in Rats [Corrigendum]
by: Pang X, et al.
Published: (2020-06-01)

Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
by: Masaud Shah, et al.
Published: (2020-01-01)

The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
by: Juanjuan Xu, et al.
Published: (2017-05-01)

Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation
by: Yaoqiang Du, et al.
Published: (2021-07-01)

A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2
by: Xiaoning Wang, et al.
Published: (2021-02-01)

Identification of Potential Semisynthetic Andrographolide Derivatives to Combat COVID-19 by Targeting the SARS-COV-2 Spike Protein and Human ACE2 Receptor– An In-silico Approach
by: Ravichandran, V.
Published: (2023)

Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBD<sub>N318-V510</sub>) Expressed in <i>Escherichia coli</i>
by: Alan Roberto Márquez-Ipiña, et al.
Published: (2021-02-01)

Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)
by: Paulo R.S. Sanches, et al.
Published: (2021-09-01)

The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies
by: Anastassios C. Papageorgiou, et al.
Published: (2020-10-01)

Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology
by: Zhi-Ling Zhu, et al.
Published: (2021-12-01)

SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment
by: Khalil Khalaf, et al.
Published: (2020-10-01)

Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer’s disease brain
by: Yuhai Zhao, et al.
Published: (2021-10-01)

TO90 inhibits angiotensin II-induced inflammatory response by up-regulating ACE2/Ang-(1-7)/MAS receptor axis in human retinal pigment epithelial cells
by: MAI Yuxin, et al.
Published: (2019-10-01)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
by: Ma’mon M. Hatmal, et al.
Published: (2020-12-01)

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
by: Qizhong Lu, et al.
Published: (2021-01-01)

Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
by: Meng-Yuan Li, et al.
Published: (2020-04-01)

A computational study on hydroxychloroquine binding to target proteins related to SARS-COV-2 infection
by: V.B. Navya, et al.
Published: (2021-01-01)

Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes
by: Esteban A. Lopera Maya, et al.
Published: (2020-06-01)